Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

ClinicalTrials.gov ID: NCT02500043

Public ClinicalTrials.gov record NCT02500043. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Phase 3 Study Evaluating TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Gastric Cancer Refractory to Standard Treatments

Study identification

NCT ID
NCT02500043
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Taiho Oncology, Inc.
Industry
Enrollment
507 participants

Conditions and interventions

Interventions

  • TAS-102 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2016
Primary completion
Apr 29, 2018
Completion
Dec 18, 2019
Last update posted
Sep 2, 2024

2016 – 2019

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Alta Bates Summit Comprehensive Cancer Center Berkeley California 94704
St. Jude Heritage Healthcare Fullerton California 92835
Los Angeles Cancer Network Los Angeles California 90017
University of Southern California - Keck School of Medicine Los Angeles California 90033
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
California Pacific Medical Center San Francisco California 94109
21st Century Oncology Jacksonville Florida 32204
Mount Sinai Hospital Medical Center Chicago Illinois 60608
Rush University Medical Center Chicago Illinois 60612
University of Chicago Chicago Illinois 60637
Illinois CancerCare P.C. Peoria Illinois 61615
University of Kentucky Lexington Kentucky 40536
University of Michigan Ann Arbor Michigan 48109
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756
Laura & Isaac Perlmutter Cancer Center New York New York 10016
Memorial Sloan Kettering Cancer Center New York New York 10065
Univeristy of Rochester Medical Center Rochester New York 14642
Wake Forest Baptist Health Winston-Salem North Carolina 27157
University of Pittsburgh Medical Cancer Center Pittsburgh Pennsylvania 15232
Roger Williams Medical Center Providence Rhode Island 02908
Coastal Bend Cancer Center Corpus Christi Texas 78404
University of Wisconsin Madison Wisconsin 53792-0001
Medical College of Wisconsin Milwaukee Wisconsin 53226-3522

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02500043, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02500043 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →